Bevacizumab

IgA-dominant membranoproliferative glomerulonephritis: case report

    Reactions Weekly volume 1838, page104(2021)Cite this article

    This is a preview of subscription content, access via your institution.

    Access options

    Buy single article

    Instant access to the full article PDF.

    US$ 49.95

    Tax calculation will be finalised during checkout.

    Reference

    1. Salman LA, et al. Bevacizumab-associated IgA-dominant membranoproliferative glomerulonephritis. Journal of the American Society of Nephrology 30 (Suppl.): 153 abstr. TH-PO157, Nov 2019. Available from: URL: https://www.asn-online.org/education/kidneyweek/archives/ [abstract]

    Download references

    Rights and permissions

    Reprints and Permissions

    About this article

    Verify currency and authenticity via CrossMark

    Cite this article

    Bevacizumab. Reactions Weekly 1838, 104 (2021). https://doi.org/10.1007/s40278-021-89423-5

    Download citation